Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Hutchins et al. (Thu,) studied this question.

www.synapsesocial.com/papers/69dd3a5f0644c7b49d40c695 — DOI: https://doi.org/10.1056/nejm199912303412706

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Commentary: Women, Research, and the National Institutes of Health· 1992 · 19 citations
2. Analysis of Treatment Failure in Acute Nonlymphocytic Leukemia Patients over Fifty Years of Age· 1992 · 14 citations
3. Prognosis among African-American women and white women with lymph node negative breast carcinoma· 1997 · 73 citations
4. Cancer of the breast in poor black women· 1989 · 165 citations
5. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group.· 1980 · 95 citations